Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus (Q38355197)

2 September 2017

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus (English)

1 reference

2 September 2017

Orthoebolavirus zairense

0 references

1 reference

Angela M Gronenborn

5

0 references

Mike Bray

series ordinal

3

object named as

Mike Bray

1 reference

2 September 2017

2

Barry R O'Keefe

1 reference

2 September 2017

Laura G Barrientos

1

1 reference

2 September 2017

Anthony Sanchez

series ordinal

4

1 reference

2 September 2017

Michael R Boyd

series ordinal

6

1 reference

2 September 2017

language of work or name

1 reference

1 March 2003

1 reference

2 September 2017

1 reference

2 September 2017

58

1 reference

2 September 2017

1

1 reference

2 September 2017

47-56

1 reference

The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Solution structure of cyanovirin-N, a potent HIV-inactivating protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Simplified procedure for fractionation and structural characterisation of complex mixtures of N-linked glycans, released from HIV-1 gp120 and other highly glycosylated viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Experimental therapy of filovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Ebola protein analyses for the determination of genetic organization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Molecular biology and evolution of filoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Ebola virus: identification of virion structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissocia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Structural basis for membrane fusion by enveloped viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Immunization for Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900183-3

7 January 2021

10.1016/S0166-3542(02)00183-3

Identifiers

DOI

1 reference

2 September 2017

1 reference